A study to assess that which antihypertensive drug minimises the risk of metabolic syndrome.
Phase 4
- Conditions
- Health Condition 1: null- Essential hypertension Stage 1
- Registration Number
- CTRI/2018/02/011814
- Lead Sponsor
- ady Hardinge Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Treatment naÑ?ve essential hypertension stage 1 patients.
Exclusion Criteria
1.Patient with comorbid type 1 or type 2 diabetes mellitus.
2.Patients taking statins or other lipid lowering agents, supplemental vitamins and antioxidants.
3.Serum triglycerides >= 150mg/dL and serum HDL cholesterol < 40mg/dL (in males) and < 50mg/dL (in females).
4.Waist circumference > 90cm (in males) and > 80cm (in females).
5.Body Mass Index > 25 kg/m2.
6.History of rheumatoid arthritis, osteoarthritis, thyroid disorder, pancreatic impairment and myocardial infarction.
7.History of smoking.
8.Patient requiring change and/or addition of another antihypertensive drug during study period.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method